Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency
Abstract Background We studied whether endothelin receptor antagonist and calcimimetic treatments influence renal damage and kidney renin-angiotensin (RA) components in adenine-induced chronic renal insufficiency (CRI). Methods Male Wistar rats (n = 80) were divided into 5 groups for 12 weeks: contr...
Main Authors: | Suvi Törmänen, Ilkka Pörsti, Päivi Lakkisto, Ilkka Tikkanen, Onni Niemelä, Timo Paavonen, Jukka Mustonen, Arttu Eräranta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-017-0742-z |
Similar Items
-
Parathyroid hormone may play a role in the pathophysiology of primary hypertension
by: Lasse Oinonen, et al.
Published: (2021-02-01) -
Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
by: Douglas S. Fuller, et al.
Published: (2019-05-01) -
A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic
by: Yuichiro Ohya, et al.
Published: (2018-05-01) -
Relationship between patients’ characteristics and efficacy of calcimimetics for primary hyperparathyroidism in the elderly
by: Koichiro Yamamoto, et al.
Published: (2022-04-01) -
Plasma total calcium concentration is associated with blood pressure and systemic vascular resistance in normotensive and never-treated hypertensive subjects
by: Lasse Oinonen, et al.
Published: (2020-05-01)